top of page
GMP Compliant
FDA-Aligned
ECOWAS Ready
Cold-Chain Enabled
/ ABOUT
Pharmadyne
Founded in March 2025 by Idris Shittu, Terry Mireku and Jeremy Rogers, Pharmadyne was established to respond to long-standing gaps in local pharmaceutical development across Africa. Inspired by evidence highlighting structural weaknesses in regional healthcare supply systems, the company was created with a clear purpose: to localise pharmaceutical packaging, support job creation and help raise standards across the sector. Pharmadyne provides packaging support including blister packs, bottles, labels and patient information leaflets, contributing to a more resilient, higher-quality pharmaceutical ecosystem.

aboutus
/ THE SOLUTION
An Integrated, Future-Ready Solution
Local Manufacturing — End-to-end GMP-certified packaging facilities producing blister packs and glass vials.
Cost & Supply Optimization — Reducing costs by 15–20% while improving supply reliability.
Traceability & Verification — Ensuring transparency and anti-counterfeiting protection.
Sustainable Packaging — Eco-friendly materials aligned with global sustainability standards.

/ SERVICES
Our Capabilities
Pharmaceutical Packaging
Primary & secondary packaging for vaccines, tablets, and biologics.
Medicine Development Support
Regulatory and lifecycle support across global markets.
Medical Logistics
Cold-chain distribution and temperature-sensitive delivery systems.
Supply Chain Infrastructure
End-to-end solutions from production to distribution.
services

/ ESG INITIATIVES
Closing the Quality Gap, One Pack at a Time.
Early Progress
-
Industrial site identified for GMP-compliant manufacturing
-
Strategic partnerships with healthcare logistics stakeholders
-
Serialization platform architecture in development
-
Expansion roadmap targeting ECOWAS regional markets
Strategic Advantages
-
First GMP-grade pharmaceutical packaging platform in Ghana
-
Integrated manufacturing and serialization technology
-
Strategic access to ECOWAS pharmaceutical markets
/ PARTNERSHIP
Strategic Partnerships & Regional Expansion
We collaborate with global health and logistics partners to ensure delivery of critical medicines.
Targeted Strategic Partnerships
Pharmadyne collaborates with key healthcare and logistics stakeholders to enhance delivery of temperature-sensitive medicines.
Cold-Chain Resilience Initiatives
Partnerships with UNICEF, Gavi, and FreezeLink strengthen cold-chain capabilities for vaccine and biologic distribution.
Regional Market Expansion
​Leveraging partnerships and AfCFTA opportunities to expand pharmaceutical packaging and logistics across ECOWAS.
Investor Assurance
Strategic alliances provide scalability, innovation, and competitiveness in a dynamic market environment.

partnership
/ THE PROBLEM
The Challenges in Emerging Pharmaceutical Supply Chains
Imported Material Dependence — Heavy reliance on PET and aluminum increases cost volatility.
Regulatory & Tax Complexity — Multiple tax layers and compliance requirements slow growth.
Skill & Technology Gaps — Limited access to advanced manufacturing and expertise.
Weak Anti-Counterfeit Systems — Lack of serialisation and verification infrastructure.
.png)
/ TEAM
Leadership & Expertise
.png)
Founder
Jeremy Rogers
Co-Founder / Co-CEO
.png)
Founder
Terry Mireku
Co-Founder / Co-CEO
.png)
Founder
Idris Shittu
Co-Founder / Co-CEO

Founder
Patricia Asante-Adofo
Chief Operations Officer
team
.png)
/ OPPORTUNITY
Positioned for Growth Across Africa
Market Growth Drivers — Healthcare demand, regulatory reforms, and local manufacturing fuel Ghana's pharmaceutical packaging market growth.
Pharmadyne Growth Outlook — Pharmadyne’s CAGR of 7–8% is supported by investments in technology, manufacturing, and regional expansion.
Investment Areas and ROI — Key investments in blister packs, glass vials, and labeling tech yield ROIs between 10–18% with quick break-even.
Regional Trade Benefits — AfCFTA alignment reduces trade barriers, enabling access to ECOWAS markets and boosting scalability.
opportunity
70%
​Pharmaceutical Products Imported
Into Ghana Annually
1.3B+
​AfCFTA Market Accessible
From Ghan
$300M+
Annual Pharmaceutical
Import Spend
~7% CAGR
Pharmaceutical Market Growth
/ CONTACT
Do You Have Any Query?
Please fill out this form. we will get back to you as soon as possible.

contactus
bottom of page

